Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy

Inclusion Criteria

• •Locally advanced or MBC with progression after at least one chemotherapeutic regimen for advanced disease eligible for treatment with eribulin according to Fachinformation. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting unless participants were not suitable for these treatments
• •1-3 prior chemotherapeutic regimens for advanced disease
• •Age \>=18 years at the time of Informed Consent
• •Ability to understand and willingness to respond to questions related to their health
• •Decision for the participant to start treatment with eribulin has been made prior to inclusion in this study.
• •Signed written Informed Consent